ThursdayJul 29, 2021 10:18 am

QualityStocksNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Announces LOI, Enters Promising Australian Medical Cannabis and OTC CBD Space

Flora Growth (NASDAQ: FLGC), an all-outdoor cultivator and manufacturer of cannabis-derived products and brands, as signed a Letter of Intent (“LOI”) with Evergreen Pharmacare Pty Ltd. Evergreen is a licensed importer and distributor of medical cannabis products based in Australia, and the LOI calls for Flora to provide raw and finished medical cannabis products for medical cannabis patients. Flora plans to ship the medical-grade cannabis products after the company obtains the correct export licenses and completes its first commercial harvest. The LOI is the second that Flora has signed since recent changes in Colombian law allow the company to sell…

Continue Reading

ThursdayJul 29, 2021 9:57 am

QualityStocksNewsBreaks – Friendable Inc. (FDBL) Featured in SmallCapVoice.com Interview

Friendable (OTC: FDBL), a mobile technology and marketing company, was featured in a new interview with SmallCapVoice.com Inc. (“SCV”). Friendable CEO Robert A. Rositano Jr. joined SCV's Stuart Smith to discuss the timely launch of the company's version 2.0 of the Fan Pass livestream artist platform and its aggressive strategy to achieve “immense scalability.” Rositano Jr. explains that the Fan Pass app is a platform and true artist partner that enables authentic interaction between artists and their fans. The app’s features are tailored to both the artist and the fan, catering to individual needs and wants, including a suite of…

Continue Reading

ThursdayJul 29, 2021 9:49 am

QualityStocksNewsBreaks – Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) Releases Third Quarter Numbers, Notes Q3 Investor Day

Tryp Therapeutics (CSE: TRYP) (OTCQB: TRYPF), a pharmaceutical company focused on developing psilocybin-based compounds for diseases with unmet medical needs through accelerated regulatory pathways, has reported its interim financial results; the results cover the three- and nine-month period ended May 31, 2021. Highlights of the report include Tryp’s collaboration with the Chronic Pain & Fatigue Research Center at the University of Michigan Medical School; the two companies will work together to conduct a Phase 2a clinical trial for fibromyalgia that is the first Phase 2 study evaluating the efficacy of a psychedelic compound for the indication. In addition, Tryp also partnered with the…

Continue Reading

ThursdayJul 29, 2021 9:46 am

QualityStocksNewsBreaks – Cybin Inc. (NEO: CYBN) (OTCQB: CLXPF) Receives Listing Approval from NYSE American

Cybin (NEO: CYBN) (OTCQB: CLXPF), a biotechnology company focused on progressing psychedelic therapeutics, has received approval for its common shares to trade on the NYSE American LLC stock exchange. According to the announcement, the company anticipates that trading to begin on or about Aug. 5, 2021; the company will trade on the exchange using the symbol CYBN. The company will continue to list its common shares in Canada on the NEO Exchange under the symbol CYBN and on the Frankfurt Stock Exchange under the symbol R7E1. Shareholders are encouraged to check their accounts to make sure that change in exchange…

Continue Reading

ThursdayJul 29, 2021 9:30 am

Imagin Medical Inc. (CSE: IME) (OTCQB: IMEXF) Proprietary Imaging System Set to Advance Bladder Cancer Visualization

Approximatively 75-85% of patients with confirmed cases of bladder cancer are diagnosed with non-muscle invasive (“NMIBC”) Imagin Medical’s innovative technology is targeting this type of bladder cancer and set to be completed in 2022  Blue light cystoscopy helps surgeons visualize the cancerous cells that are not detected by white light, enabling an improved resection Non-muscle-invasive bladder cancer (“NMIBC”) is a type of bladder cancer that has not infiltrated the other muscle tissues inside the bladder or spread to the lymph nodes. Approximately 75-85% of patients presenting with bladder cancer are diagnosed with NMIBC. The most common symptoms of NMIBC which…

Continue Reading

ThursdayJul 29, 2021 9:30 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Hails Successful Testing for Effective Transformation of Antivirals for Greater Bioavailability

Lexaria Bioscience is a drug delivery technology developer advancing its IP for transforming existing consumer products and medications that may improve their availability and bioavailability The analysis of Lexaria’s DehydraTECH(TM) shows it did not create unwanted new molecular entities during the transformation process, did not inhibit the drugs’ expected antiviral functions and did increase absorption The DehydraTECH testing has been in conjunction with drugs used to treat SARS-CoV-2/COVID-19, HIV/AIDS and hepatitis, although the company envisions its technology becoming responsive to a much wider array of viral illnesses The company envisions building on its recent successes with larger studies of the…

Continue Reading

ThursdayJul 29, 2021 9:00 am

Green Hygienics Holdings Inc. (GRYN) to Become First Hemp Company to Develop ESG Report Using SASB Framework

The company plans to incorporate systemic environmental, social, and governance (“ESG”) factors into business planning and investment decision-making The initial Sustainability Accounting Standards Board (“SASB”) report has been completed, and sustainability consulting firm KERMIDA Inc. is currently organizing the data compiled by Green Hygienics An ESG program can significantly benefit companies in the industry, from drawing in more investors to winning new business, gaining better talent and improving media coverage The industrial hemp market size is expected to reach $15.26 billion by 2027 due to the rising demand for food, supplements, cosmetics, and personal care items Green Hygienics Holdings (OTCQB:…

Continue Reading

ThursdayJul 29, 2021 9:00 am

Friendable, Inc. (FDBL), Its Technology, Innovation, and Commitment to Artists

The single biggest slice of an artists’ earnings (28%) comes from touring, meaning live performances, and, with the pandemic, artists were restricted in doing live shows Friendable addresses this with its Fan Pass platform, allowing artists to make money from virtual events, video content views, artist contests, merchandise sales, and even ticket sales Friendable continues to innovate and leverage technology to address the new challenges that artists face As of early 2020, touring, shows, and live performances accounted for much of an artists’ earnings, at 28%. This was closely followed by teaching at 22%, salaries at 19%, session playing at…

Continue Reading

ThursdayJul 29, 2021 9:00 am

RYAH Group Inc. (CSE: RYAH) Globally Unlocking Data in the Complete Therapeutic Plant Lifecycle

Providing a holistic approach to therapeutic plant treatment by unlocking data from seed to consumption RYAH Group is providing needed dosing devices globally to drive innovation and deliver cutting edge plant-based medical solutions globally  With over 200k registered users, RYAH Group is one of the largest plant-based medicine databases in the world and regularly releases and shares valuable insights collected RYAH Group (CSE: RYAH), formerly RYAH Medtech, is leading the way forward by providing a holistic approach to therapeutic plant treatment by unlocking the data in the complete plant lifecycle (seed to consumption). Known for its high-quality information and digital…

Continue Reading

WednesdayJul 28, 2021 3:24 pm

QualityStocksNewsBreaks – Mobius Interactive Ltd. Targets Pioneering Step in Expanding Industry

Mobius Interactive, an online esports and gaming operator launched by a team of gaming industry professionals in 2020, has created and produced three new and diverse global brands: Mobius.bet, Club Double and Aragon Casino, with each of these brands targeting a different audience. “The team at Mobius Interactive brings over 40 years of collective gaming experience to the table and has successfully launched over 30 products within the last three years. The company is poised to go public later this year,” reads a recent article. As a member of the Mobius team, Nicholas de Freitas, Mobius’ VP of Marketing, is…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

Register

Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered